JP2022512922A5 - - Google Patents
Info
- Publication number
- JP2022512922A5 JP2022512922A5 JP2021524069A JP2021524069A JP2022512922A5 JP 2022512922 A5 JP2022512922 A5 JP 2022512922A5 JP 2021524069 A JP2021524069 A JP 2021524069A JP 2021524069 A JP2021524069 A JP 2021524069A JP 2022512922 A5 JP2022512922 A5 JP 2022512922A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- transmembrane domain
- car
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862756294P | 2018-11-06 | 2018-11-06 | |
| US62/756,294 | 2018-11-06 | ||
| US201962788440P | 2019-01-04 | 2019-01-04 | |
| US62/788,440 | 2019-01-04 | ||
| PCT/US2019/060005 WO2020097164A1 (en) | 2018-11-06 | 2019-11-06 | Chimeric antigen receptor memory-like (carml) nk cells and methods of making and using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512922A JP2022512922A (ja) | 2022-02-07 |
| JP2022512922A5 true JP2022512922A5 (cg-RX-API-DMAC7.html) | 2022-11-14 |
Family
ID=70612473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524069A Pending JP2022512922A (ja) | 2018-11-06 | 2019-11-06 | キメラ抗原受容体記憶様(carml)nk細胞ならびにその産生および使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220073585A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3876961A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022512922A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210090220A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113423409A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019377461A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3117206A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL282850A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202104287RA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020097164A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113226340A (zh) | 2018-11-26 | 2021-08-06 | 恩卡尔塔公司 | 同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途 |
| KR20210137085A (ko) | 2019-03-05 | 2021-11-17 | 엔카르타, 인크. | Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도 |
| US11459372B2 (en) | 2020-11-30 | 2022-10-04 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
| EP4271798A1 (en) | 2020-12-30 | 2023-11-08 | CRISPR Therapeutics AG | Compositions and methods for differentiating stem cells into nk cells |
| US20240115607A1 (en) * | 2021-01-26 | 2024-04-11 | Cytocares (Shanghai) Inc. | Chimeric antigen receptor (car) constructs and nk cells expressing car constructs |
| WO2022171179A1 (zh) * | 2021-02-10 | 2022-08-18 | 苏州克睿基因生物科技有限公司 | 一种扩增增强子及其应用 |
| US20230330228A1 (en) | 2022-03-22 | 2023-10-19 | WUGEN, Inc. | Hybrid promoters, vectors containing same and methods of use |
| WO2025067318A1 (zh) * | 2023-09-28 | 2025-04-03 | 沛尔生技医药股份有限公司 | 具有细胞内信号传导结构域及自然杀伤蛋白30跨膜结构域的核酸分子及包含其的嵌合抗原受体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130266551A1 (en) * | 2003-11-05 | 2013-10-10 | St. Jude Children's Research Hospital, Inc. | Chimeric receptors with 4-1bb stimulatory signaling domain |
| KR20140060541A (ko) * | 2011-09-16 | 2014-05-20 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 암을 치료하기 위한 rna 조작된 t 세포 |
| SG11201505858VA (en) * | 2013-01-28 | 2015-09-29 | St Jude Childrens Res Hospital | A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease |
| SG10202109752XA (en) * | 2014-04-07 | 2021-10-28 | Novartis Ag | Treatment of cancer using anti-cd19 chimeric antigen receptor |
| AU2015292744C1 (en) * | 2014-07-21 | 2021-01-21 | Novartis Ag | Treatment of cancer using humanized anti-BCMA chimeric antigen receptor |
| ES2738705T3 (es) * | 2014-09-19 | 2020-01-24 | Hope City | Linfocitos T de receptor de antígeno quimérico coestimulante que se dirigen a IL13R 2 |
| CN113862292B (zh) * | 2015-01-29 | 2024-12-27 | 明尼苏达大学董事会 | 嵌合抗原受体、组合物以及方法 |
| US11932870B2 (en) * | 2016-12-05 | 2024-03-19 | Fate Therapeutics, Inc. | Compositions and methods for immune cell modulation in adoptive immunotherapies |
| AU2018240556B2 (en) * | 2017-03-24 | 2025-02-27 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-CD33 immunotherapy |
| KR102742741B1 (ko) * | 2017-10-18 | 2024-12-16 | 프레시전 인코포레이티드 | 스페이서를 포함하는 폴리펩타이드 조성물 |
| CN108219004A (zh) * | 2018-02-08 | 2018-06-29 | 吉林省拓华生物科技有限公司 | 双特异嵌合抗原受体修饰的t细胞、其制备方法及用途 |
| JP7723420B2 (ja) * | 2019-08-28 | 2025-08-14 | キングス・カレッジ・ロンドン | B細胞標的化並列CAR(pCAR)治療的薬剤 |
-
2019
- 2019-11-06 AU AU2019377461A patent/AU2019377461A1/en not_active Abandoned
- 2019-11-06 KR KR1020217017370A patent/KR20210090220A/ko not_active Ceased
- 2019-11-06 JP JP2021524069A patent/JP2022512922A/ja active Pending
- 2019-11-06 EP EP19882787.5A patent/EP3876961A4/en not_active Withdrawn
- 2019-11-06 CA CA3117206A patent/CA3117206A1/en active Pending
- 2019-11-06 WO PCT/US2019/060005 patent/WO2020097164A1/en not_active Ceased
- 2019-11-06 CN CN201980088089.2A patent/CN113423409A/zh active Pending
- 2019-11-06 US US17/291,959 patent/US20220073585A1/en active Pending
- 2019-11-06 SG SG11202104287RA patent/SG11202104287RA/en unknown
-
2021
- 2021-05-02 IL IL282850A patent/IL282850A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240093232A1 (en) | Retroviral And Lentiviral Vectors | |
| Cerwenka et al. | Natural killer cell memory in infection, inflammation and cancer | |
| JP2025031794A5 (cg-RX-API-DMAC7.html) | ||
| CN107735407B (zh) | 治疗剂 | |
| JP6695347B2 (ja) | レトロウイルスおよびレンチウイルスベクター | |
| JP2018526033A5 (cg-RX-API-DMAC7.html) | ||
| US20220064595A1 (en) | Multi-target chimeric antigen receptor | |
| JP2020058380A (ja) | キメラ抗原受容体及びその製造方法 | |
| WO2022007795A1 (zh) | 一种嵌合受体及其应用 | |
| CN114599785A (zh) | 工程化的t细胞及其产生方法 | |
| RU2020117772A (ru) | Векторы | |
| JP2021500905A5 (cg-RX-API-DMAC7.html) | ||
| JP2024525609A5 (cg-RX-API-DMAC7.html) | ||
| EP3753566A1 (en) | All-in one viral vector for car and therapeutic effector molecule | |
| CN115835873A (zh) | 用于产生表达重组受体的供体分批细胞的方法 | |
| CN117677633A (zh) | 基于nkg2d的嵌合抗原受体 | |
| JP2024514942A5 (cg-RX-API-DMAC7.html) | ||
| CN119137262A (zh) | 经改造细胞及使用方法 | |
| US20220118014A1 (en) | Placenta-derived allogeneic car-t cells and uses thereof | |
| CN121969385A (zh) | 含有il-2变体以增强car t细胞的功能性的car-衔接子 | |
| US20240368626A1 (en) | T-cell manufacturing methods | |
| Mesci et al. | A rapid and efficient method for the generation and screening of monoclonal antibodies specific for cell surface antigens | |
| CN110863014A (zh) | 改进的慢病毒载体 | |
| Ruddle | T cell hybrids with specificity for individual antigens | |
| RU2021116146A (ru) | Nk-клетки с химерным антигенным рецептором, подобные клеткам памяти (carml), и способы их получения и примения |